0.9 % Sodium Chloride
Brand names: Sodium Chloride
At a glance
- Medicare prescriptions, 2024
- 246,188
- Medicare drug cost
- $5.9M
- Average cost per prescription
- $24.03
- Clinicians who prescribed it
- 7,845
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
23.4% Sodium Chloride Injection, USP is indicated for use as an electrolyte replenisher in parenteral fluid therapy. It serves as an additive for total parenteral nutrition (TPN) and as an additive for carbohydrate containing I.V. fluids.
From the FDA-approved prescribing information (label dated November 2025). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Internal Medicine 25.8%
- Family Medicine 15.3%
- Nurse Practitioners 11.9%
- Infectious Disease 8.8%
- Neurology 7.7%
- Gastroenterology 6.2%
- Geriatric Medicine 3.3%
- Physician Assistants 2.6%
- Hospitalist 2.5%
- Hematology & Oncology 2.0%
- Nephrology (Kidney) 1.9%
- Rheumatology 1.8%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 44% from 2019 to 2024.
Biggest change by state since 2019
- Texas +88%
- Alabama +80%
- North Carolina +68%
- Florida +60%
- New York +52%
- Michigan (smallest change) −2%
- Kentucky (smallest change) +3%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
Drug makers reported $96 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- B. Braun Medical Inc. $96
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.